Search results
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 5 hours agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
How Much Will Pfizer Pay Out in Dividends This Year? | The Motley Fool
The Motley Fool· 3 days agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (PFE 0.66%) a household name in recent years, but this isn't all the company ...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 6 days agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 6 days agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 5 days ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 5 days agoUnlike the COVID-19 pandemic, when the U.S. government subsidized private companies to make the COVID...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 6 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever
Motley Fool via Yahoo Finance· 4 days agoThe company struck gold with its decision to enter the COVID-19 vaccine market. Beyond the...
The Savvy Investor’s Cheat Sheet: 3 Deep Value Picks for May 2024
InvestorPlace via Yahoo Finance· 6 days agoWith many market strategists turning slightly bullish amid this bull market, investors may wonder if...